COVID - 19 Vaccination Update - Day 523 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 22 JUN 2022 8:05 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 196.60 Crore (1,96,60,12,817) today. More than 12 lakh (12,95,158) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10408464
	2^nd Dose	10058923
	Precaution Dose	5573327
FLWs	1^st Dose	18422513
	2^nd Dose	17615988
	Precaution Dose	9787110
Age Group 12-14 years	1^st Dose	35989833
	2^nd Dose	21756290
Age Group 15-18 years	1^st Dose	60188685
	2^nd Dose	48026991
Age Group 18-44 years	1^st Dose	557986244
	2^nd Dose	498903545
	Precaution Dose	2219933
Age Group 45-59 years	1^st Dose	203400899
	2^nd Dose	192892240
	Precaution Dose	2196515
Over 60 years	1^st Dose	127217997
	2^nd Dose	120449364
	Precaution Dose	22917956
Cumulative 1^st dose administered		1013614635
Cumulative 2^nd dose administered		909703341
Precaution Dose		42694841
Total		1966012817

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 22^nd June, 2022 (523^rd Day)
HCWs	1^st Dose	56
	2^nd Dose	1331
	Precaution Dose	16319
FLWs	1^st Dose	151
	2^nd Dose	1828
	Precaution Dose	59966
Age Group 12-14 years	1^st Dose	82814
	2^nd Dose	218179
Age Group 15-18 years	1^st Dose	26072
	2^nd Dose	80188
Age Group 18-44 years	1^st Dose	27323
	2^nd Dose	312405
	Precaution Dose	61334
Age Group 45-59 years	1^st Dose	4497
	2^nd Dose	72149
	Precaution Dose	32491
Over 60 years	1^st Dose	3841
	2^nd Dose	52757
	Precaution Dose	241457
Cumulative 1^st dose administered		144754
Cumulative 2^nd dose administered		738837
Precaution Dose		411567
Total		1295158

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.